miRNA-34a is associated with docetaxel resistance in human breast cancer cells

被引:181
作者
Kastl, L. [1 ]
Brown, I. [1 ]
Schofield, A. C. [1 ]
机构
[1] Univ Aberdeen, Sch Med, Sch Med & Dent, Div Appl Med,Coll Life Sci & Med, Aberdeen AB25 2ZD, Scotland
关键词
Breast cancer cells; Docetaxel; Drug resistance; miRNA; CYCLIN D1; CARCINOMA CELLS; DOWN-REGULATION; MULTIDRUG-RESISTANCE; TARGETING BCL2; MCF-7; CELLS; PC3; APOPTOSIS; EXPRESSION; MIR-34A;
D O I
10.1007/s10549-011-1424-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Docetaxel is a chemotherapy drug to treat breast cancer, however as with many chemotherapeutic drugs resistance to docetaxel occurs in 50% of patients, and the underlying molecular mechanisms of drug resistance are not fully understood. Gene regulation through microRNAs (miRNA) has been shown to play an important role in cancer drug resistance. By directly targeting mRNA, miRNAs are able to inhibit genes that are necessary for signalling pathways or drug induced apoptosis rendering cells drug resistant. This study investigated the role of differential miRNA expression in two in vitro breast cancer cell line models (MCF-7, MDA-MB-231) of acquired docetaxel resistance. MiRNA microarray analysis identified 299 and 226 miRNAs altered in MCF-7 and MDA-MB-231 docetaxel-resistant cells, respectively. Docetaxel resistance was associated with increased expression of miR-34a and miR-141 and decreased expression of miR-7, miR-16, miR-30a, miR-125a-5p, miR-126. Computational target prediction revealed eight candidate genes targeted by these miRNAs. Quantitative PCR and western analysis confirmed decreased expression of two genes, BCL-2 and CCND1, in docetaxel-resistant cells, which are both targeted by miR-34a. Modulation of miR-34a expression was correlated with BCL-2 and cyclin D1 protein expression changes and a direct interaction of miR-34a with BCL-2 was shown by luciferase assay. Inhibition of miR-34a enhanced response to docetaxel in MCF-7 docetaxel-resistant cells, whereas overexpression of miR-34a conferred resistance in MCF-7 docetaxel-sensitive cells. This study is the first to show differences in miRNA expression, in particular, increased expression of miR-34a in an acquired model of docetaxel resistance in breast cancer. This serves as a mechanism of acquired docetaxel resistance in these cells, possibly through direct interactions with BCL-2 and CCND1, therefore presenting a potential therapeutic target for the treatment of docetaxel-resistant breast cancer.
引用
收藏
页码:445 / 454
页数:10
相关论文
共 53 条
[31]  
Lukyanova N. Yu., 2009, Experimental Oncology, V31, P87
[32]   Downregulation of miR-21 Enhances Chemotherapeutic Effect of Taxol in Breast Carcinoma Cells [J].
Mei, Mei ;
Ren, Yu ;
Zhou, Xuan ;
Yuan, Xu-bo ;
Han, Lei ;
Wang, Guang-xiu ;
Jia, Zhifan ;
Pu, Pei-yu ;
Kang, Chun-sheng ;
Yao, Zhi .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2010, 9 (01) :77-86
[33]   MicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1 [J].
Miller, Tyler E. ;
Ghoshal, Kalpana ;
Ramaswamy, Bhuvaneswari ;
Roy, Satavisha ;
Datta, Jharna ;
Shapiro, Charles L. ;
Jacob, Samson ;
Majumder, Sarmila .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (44) :29897-29903
[34]   How microRNAs control cell division, differentiation and death [J].
Miska, EA .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2005, 15 (05) :563-568
[35]   Prediction of response to docetaxel by immunohistochemical analysis of CYP3A4 expression in human breast cancers [J].
Yasuo Miyoshi ;
Tetsuya Taguchi ;
Seung Jin Kim ;
Yasuhiro Tamaki ;
Shinzaburo Noguchi .
Breast Cancer, 2005, 12 (1) :11-15
[36]   Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer [J].
Modok, Szabolcs ;
Mellor, Howard R. ;
Callaghan, Richard .
CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (04) :350-354
[37]   Physiological identification of human transcripts translationally regulated by a specific microRNA [J].
Nakamoto, M ;
Jin, P ;
O'Donnell, WT ;
Warren, ST .
HUMAN MOLECULAR GENETICS, 2005, 14 (24) :3813-3821
[38]   Predictive factors for response to docetaxel in human breast cancers [J].
Noguchi, Shinzaburo .
CANCER SCIENCE, 2006, 97 (09) :813-820
[39]   MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer Cells [J].
Pan, Yu-Zhuo ;
Morris, Marilyn E. ;
Yu, Ai-Ming .
MOLECULAR PHARMACOLOGY, 2009, 75 (06) :1374-1379
[40]  
RESNITZKY D, 1995, MOL CELL BIOL, V15, P3463